Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Methylene Blue Is a Muscarinic Antagonist in Cardiac Myocytes

Najah Abi-Gerges, Thomas Eschenhagen, Leif Hove-Madsen, Rodolphe Fischmeister and Pierre-François Mery
Molecular Pharmacology September 1997, 52 (3) 482-490; DOI: https://doi.org/10.1124/mol.52.3.482
Najah Abi-Gerges
Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446,Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Eschenhagen
Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446,Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leif Hove-Madsen
Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446,Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodolphe Fischmeister
Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446,Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-François Mery
Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446,Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We studied the mechanism of action of methylene blue (Mblue), a putative guanylyl cyclase inhibitor, on the L-type calcium current (ICa) and the muscarinic activated K+ current (IK,ACh) in rat ventricular and atrial myocytes, respectively, and on the binding of [3H]quinuclidinyl benzylate in rat ventricular membranes. Superfusion, but not internal dialysis, with 30 μm Mblue antagonized the inhibitory effect of acetylcholine (ACh, 1 μm) on β-adrenergic stimulation of ICa with isoprenaline (Iso, 10 nm or 1 μm). However, Mblue had no effect on the basal ICa or on the stimulation of ICa by Iso in the absence of ACh. The activation of IK,ACh by 3 μm ACh was also antagonized by Mblue in a dose-dependent manner. In contrast, Mblue had no effect on the activation of IK,ACh by either guanosine-5′-O-(3-thio)triphosphate or guanosine-5′-(β,γ-imido)triphosphate. Chlorpromazine (CPZ), a piperazine derivative like Mblue, also inhibited the muscarinic activation of IK,ACh in a dose-dependent manner. The specific binding of [3H]QNB, a muscarinic ligand, to rat ventricular membranes was displaced in a dose-dependent manner by Mblue and CPZ. The piperazine derivatives behaved like competitive antagonists of [3H]QNB binding, exhibiting equilibrium dissociation constant (Ki ) values of 187 nm for Mblue and 366 nm for CPZ. In conclusion, Mblue exerts antimuscarinic effects on ICaand IK,ACh in rat cardiac myocytes that are best explained by the binding of Mblue to the M2 subtype of muscarinic receptors. This property probably contributes to the antimuscarinic effect of the putative guanylyl cyclase inhibitor reported in previous studies.

Footnotes

    • Received January 23, 1997.
    • Accepted June 2, 1997.
  • Send reprint requests to: Dr. Pierre-François Mery, INSERM U-446, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France. E-mail: u446{at}vjf.inserm.fr

  • ↵1 Current affiliation: Pharmakologisches Institut, Universitäts-Krankenhaus Eppendorf, D-2000 Hamburg 20–38, Germany.

  • ↵2 Current affiliation: Department of Biologia Celular, Fisiologia Animal, Fac. Ciencias, Universidad Autonoma de Barcelona, E-08193 Cerdanyola, Spain.

  • This work was supported by a grant from the Association Française contre les Myopathies. L.H.-M. was a Fellowship recipient of the Carlsberg Foundation. T.E. was supported by a grant from the Deutsche Forschungsgemeinschaft.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (3)
Molecular Pharmacology
Vol. 52, Issue 3
1 Sep 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Methylene Blue Is a Muscarinic Antagonist in Cardiac Myocytes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Methylene Blue Is a Muscarinic Antagonist in Cardiac Myocytes

Najah Abi-Gerges, Thomas Eschenhagen, Leif Hove-Madsen, Rodolphe Fischmeister and Pierre-François Mery
Molecular Pharmacology September 1, 1997, 52 (3) 482-490; DOI: https://doi.org/10.1124/mol.52.3.482

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Methylene Blue Is a Muscarinic Antagonist in Cardiac Myocytes

Najah Abi-Gerges, Thomas Eschenhagen, Leif Hove-Madsen, Rodolphe Fischmeister and Pierre-François Mery
Molecular Pharmacology September 1, 1997, 52 (3) 482-490; DOI: https://doi.org/10.1124/mol.52.3.482
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics